Mitsubishi Chemical Group Corporation

03/13/2025 | Press release | Distributed by Public on 03/12/2025 20:05

【Mitsubishi Tanabe Pharma】Filling for a Oral Edaravone Formulation for the treatment of ALS in KoreaNEW